Decreased susceptibility to vancomycin in meticillin-resistant Staphylococcus aureus: A 5 year study in an Indian tertiary hospital

Journal of Medical Microbiology

Volumn 59, Issue 3, 2010, Pages 375-376

  Dhawan, Benu ^a   Gadepalli, Ravisekhar ^a   Rao, Chandrabhan ^a   Kapil, Arti ^a   Sreenivas, V ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; INDIA; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS INFECTION; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; HOSPITALS; HUMANS; INDIA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 76649115876     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.011940-0     Document Type: Letter

References (14)

1. Biedenbach, D. J., Moet, G. J. & Jones, R. N. (2004). Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 50, 59-69.
2. Chapman, A. L., Greig, J. M. & Innes, J. A. (2005). MRSA in the community. N Engl J Med 353, 530-532.
3. CLSI (2006a). Performance Standards for Antimicrobial Susceptibility Testing, 16th informational supplement, M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute.
4. CLSI (2006b). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th edn, approved standard M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Dhawan, B., Gadepalli, R. & Kapil, A. (2009). In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India. Diagn Microbiol Infect Dis 65, 196-198.
6. Fridkin, S. K., Hageman, J., McDougal, L. K., Mohammed, J., Jarvis, W. R., Perl, T. M. & Tenover, F. C, for the Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group (2003). Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 36, 429-439.
7. Gadepalli, R., Dhawan, B., Kapil, A., Sreenivas, V., Jais, M., Gaind, R., Chaudhry, R., Samantaray, J. C. & Udo, E. E. (2009). Clinical and molecular characteristics of nosocomial meticillin-resistant Staphylococcus aureus skin and soft tissue isolates from three Indian hospitals. J Hosp Infect 73, 253-263.
8. Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y. & Kobayashi, I. (1997). Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350, 1670-1673.
9. Mathur, P., Kapil, A., Chandra, R., Sharma, P. & Das, B. (2003). Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of northern India. Indian J Med Res 118, 25-28.
10. NNISS (2004). National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32, 470-485.
11. Ramos-Trujillo, E., Pérez-Roth, E., Méndez-Alvarez, S. & Claverie-Martín, F. (2003). Multiplex PCR for simultaneous detection of enterococcal genes vanA and vanB and staphylococcal genes mecA, ileS-2 and femB. Int Microbiol 6, 113-115.
12. Robert, J., Bismuth, R. & Jarlier, V. (2006). Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002. J Antimicrob Chemother 57, 506-510.
13. Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., Jr & Eliopoulos, G. M. (2004). Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 42, 2398-2402.
14. Tenover, F. C. (2008). Vancomycin-resistant Staphylococcus aureus: a perfect but geographically limited storm? Clin Infect Dis 46, 675-677.